Filing Flows › Myomo (MYO) › Q1 2026 › vs Q1 2025
Myomo (MYO) Q1 2026 vs Q1 2025 (year over year)
Myomo's revenue rose $281K (+3%) from $9.8M in Q1 2025 to $10.1M in Q1 2026.
Myomo, Q1 2026: revenue $10.1M (+3% year over year), operating margin -31.2%, net loss $3.0M, operating cash flow −$2.2M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $10.1M | $9.8M | $281K | +3% |
| Other income, net | $334K | $192K | $142K | +74% |
| Net loss | $3.0M | $3.5M | −$456K | -13% |
| Costs & expenses | $13.5M | $13.5M | −$32K | -0.2% |
| Operating costs | $13.3M | $13.4M | −$82K | -0.6% |
| Income tax | $187K | $137K | $50K | +36% |
| Cost of revenue | $3.2M | $3.2M | −$11K | -0.3% |
| Research & development | $1.6M | $1.8M | −$167K | -9% |
| Sales & marketing | $4.8M | $4.4M | $421K | +10% |
| General & admin | $3.6M | $3.9M | −$325K | -8% |
| Operating cash sources | $3.1M | $3.4M | −$289K | -9% |
| Depreciation & amortization | $292K | $158K | $133K | +84% |
| Share-based compensation | $597K | $540K | $57K | +11% |
| Cash used in operations | $2.2M | $2.7M | −$480K | -18% |
| Net loss absorbed | $3.0M | $3.5M | −$456K | -13% |
| Working capital & other | $77K | −$90K | $166K | — |
Questions
How much did Myomo's revenue grow year over year in Q1 2026?
Myomo's revenue rose $281K (+3%) from $9.8M in Q1 2025 to $10.1M in Q1 2026.